This site uses cookies to remember your language and measure which pages help. Accept all, or keep only what is necessary. Details in our Cookie Policy.

Medical Device Component Sourcing in China

Components, housings and assemblies for medical devices: ISO 13485 scope, cleanroom class, and the validation documents a buyer inherits.

On this page9 sections
  1. What buyers get wrong
  2. The categories we handle
  3. Documents and certifications that matter
  4. What we check inside the plant
  5. Which belts fit which product
  6. Where the cost sits
  7. Failure modes at this stage
  8. How an engagement runs
  9. Next step

Medical sourcing is not harder because the parts are difficult — most of them are ordinary machined or moulded components. It is harder because the paperwork is part of the product, and a supplier that cannot produce the paperwork cannot supply the device.

What buyers get wrong

  • Buying an ISO 13485 certificate without reading its scope. A scope covering “distribution” says nothing about manufacturing your component.
  • Assuming cleanroom moulding includes cleanroom packing. The two are separate and the second is where bioburden appears.
  • Skipping process validation. IQ, OQ and PQ are the supplier’s obligation, and your auditor will ask for them.
  • No change control clause. A resin change with the same trade name and a different supplier is a regulatory event, not a cost improvement.

The categories we handle

  • Machined components — surgical instrument parts, housings, connectors, fixtures.
  • Moulded components — catheter parts, fluid path components, device housings, consumable bodies.
  • Assemblies — sub-assemblies with bonding, welding or packaging steps.
  • Consumables and packaging — trays, pouches, thermoformed packaging, labels.
  • Electronics — sensor boards and cable assemblies for device builds.

Documents and certifications that matter

  • ISO 13485 — current certificate, notified body, and a scope that names the process you are buying.
  • EU MDR 2017/745 — the component supplier does not hold the CE mark, but must support your technical file: material declarations, process validation, bioburden data, sterilisation compatibility.
  • US FDA — for components, the relevant output is supplier control evidence under 21 CFR 820.50, not a 510(k).
  • ISO 10993 — biocompatibility test data for patient-contacting materials, on the finished device but sourced from material and process data.
  • ISO 14971 — risk management inputs, especially for process-related risks the supplier owns.
  • Cleanroom — ISO 14644 class certification with particle counts, plus the monitoring records, not just the class claim.

What we check inside the plant

  • Whether the cleanroom is actually running at class, with gowning procedure and particle logs.
  • Process validation files for the specific process, not for a similar part.
  • Whether production and non-conforming material share an air handler.
  • Traceability from resin lot or bar stock to finished lot, and how it is recorded.
  • How deviations are handled when a validation parameter is missed.

Which belts fit which product

  • Precision and instrument parts — Suzhou and the Yangtze delta cluster.
  • Moulded consumables — Dongguan and Shenzhen, where tooling speed is the advantage.
  • Packaging and trays — Foshan and the Dongguan packaging belt.
  • Electronics — Shenzhen and Suzhou, depending on the class of board.

Where the cost sits

The part cost is often the smaller number. Validation, cleanroom overhead, documentation and lot retention typically add 20–40% on top of an equivalent industrial component, and that premium does not fall with volume. Buyers who compare a medical moulding against an industrial moulding and expect the gap to close are usually disappointed; the honest comparison is total cost of a qualified supplier.

Failure modes at this stage

  • Cleanroom class claimed but monitoring records missing for the production period.
  • Validation performed on a surrogate part, then transferred without re-validation.
  • Resin substituted under the same generic name, invalidating biocompatibility data.
  • Documentation delivered as scans that cannot be traced back to a lot.

How an engagement runs

We start with the drawing, the intended use and the regulatory pathway, because those decide which documents are non-negotiable. Then a supplier screen on scope and process, then a documentation gap list, then a site audit with the buyer’s quality lead. We treat the first article as a validation event rather than a sample approval, and we keep the record set in one place so the technical file can be assembled without a second round of requests.

Next step

Send the drawing, the material, the intended use and the target market. We will tell you which suppliers can support the regulatory file and which can only make the part. Submit a request, or read supplier verification.

Need a price? 3 fields · reply in 1 business day
Get a quote